Health

Mediterranean diet can reduce risk of stroke by up to 25%, long-term study suggests

Two-decade study indicates a diet rich in foods such as olive oil, nuts and vegetables can cut risk of every type of stroke

Things reek, stink and pong – but why are there no verbs for describing a delightful odour?

We don’t have a single verb to express smelling something nice. Welsh and Croatian, by contrast, are never caught short when something fragrant gets right up your nose

Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The split in outlook underscores Lilly's strong position in the obesity market, underpinned by more effective drugs and its direct-to-consumer sales strategy.

We're raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat

Combined sales for the company's blockbuster GLP-1 drugs Zepbound and Mounjaro exceeded $1 billion, with each showing triple-digit growth.

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.

Millions may drop ACA coverage

Some experts warn of a potential "death spiral" in the Affordable Care Act marketplace if young, healthy consumers drop coverage amid soaring costs.